We are live on ! Find out more
CHA

Carmichael Hill & Associates Portfolio holdings

AUM $282M
1-Year Est. Return 32.52%
This Fund
S&P 500
This Quarter Est. Return
-13.77%
1 Year Est. Return
+32.52%
3 Year Est. Return
+39.72%
5 Year Est. Return
+107.55%
10 Year Est. Return
AUM
$190M
AUM Growth
-$26.8M
Cap. Flow
-$8.11M
Cap. Flow %
-4.26%
Top 10 Hldgs %
29.67%
Holding
887
New
63
Increased
175
Reduced
103
Closed
145

Sector Composition

Rank Sector Weight
1 Technology 14.04%
2 Financials 6.02%
3 Healthcare 5.44%
4 Consumer Staples 4.55%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMND icon
726
Lemonade
LMND
$4.1B
$2K ﹤0.01%
124
-200
-62% -$4.21K
LNC icon
727
Lincoln National
LNC
$8.82B
$2K ﹤0.01%
51
MNST icon
728
Monster Beverage
MNST
$91.5B
$2K ﹤0.01%
+46
New +$2K
NET icon
729
Cloudflare
NET
$100B
$2K ﹤0.01%
53
RUN icon
730
Sunrun
RUN
$2.49B
$2K ﹤0.01%
79
SCCO icon
731
Southern Copper
SCCO
$146B
$2K ﹤0.01%
+33
New +$1.91K
SJM icon
732
J.M. Smucker
SJM
$12.6B
$2K ﹤0.01%
14
UPBD icon
733
Upbound Group
UPBD
$1.18B
$2K ﹤0.01%
100
WEC icon
734
WEC Energy
WEC
$35.6B
$2K ﹤0.01%
18
WSFS icon
735
WSFS Financial
WSFS
$4.19B
$2K ﹤0.01%
+44
New +$1.81K
ZD icon
736
Ziff Davis
ZD
$1.99B
$2K ﹤0.01%
29
XYZ
737
Block Inc
XYZ
$48.9B
$2K ﹤0.01%
26
BBBY
738
DELISTED
Bed Bath & Beyond Inc
BBBY
$2K ﹤0.01%
500
MNDT
739
DELISTED
Mandiant, Inc. Common Stock
MNDT
$2K ﹤0.01%
90
BHVN
740
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2K ﹤0.01%
17
ADAP
741
DELISTED
Adaptimmune Therapeutics
ADAP
$1K ﹤0.01%
525
ADM icon
742
Archer Daniels Midland
ADM
$37.6B
$1K ﹤0.01%
+18
New +$1.57K
AEO icon
743
American Eagle Outfitters
AEO
$2.99B
$1K ﹤0.01%
128
ALB icon
744
Albemarle
ALB
$14B
$1K ﹤0.01%
+5
New +$1.11K
APD icon
745
Air Products & Chemicals
APD
$65.2B
$1K ﹤0.01%
+6
New +$1.46K
ASAN icon
746
Asana
ASAN
$1.97B
$1K ﹤0.01%
75
AUTL
747
Autolus Therapeutics
AUTL
$484M
$1K ﹤0.01%
508
BNY
748
Bank of New York Mellon
BNY
$106B
$1K ﹤0.01%
12
BKR icon
749
Baker Hughes
BKR
$60.4B
$1K ﹤0.01%
+43
New +$1.45K
BNTX icon
750
BioNTech
BNTX
$23.3B
$1K ﹤0.01%
10

Similar funds

Carmichael Hill & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Carmichael Hill & Associates held 887 positions worth $190M, down 12% from $217M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Carmichael Hill & Associates withdrew a net $8.11M in Q2 2022, closing 145 positions and reducing 103 holdings. Its most notable exit was Canadian National Railway, an estimated $80K position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Carmichael Hill & Associates opened a new position in Flagstar Bank National Association worth $473K.

  • Carmichael Hill & Associates's largest Q2 2022 buy was Flagstar Bank National Association: 17,287 shares worth $473K.
  • Carmichael Hill & Associates added most to Vanguard Tax-Exempt Bond Index Fund in Q2 2022, an estimated $3.72M increase.
  • Carmichael Hill & Associates's biggest Q2 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $403K.
  • Carmichael Hill & Associates fully exited Canadian National Railway in Q2 2022, selling an estimated $80K.
  • Carmichael Hill & Associates's ten largest holdings make up 30% of its $190M portfolio in Q2 2022.
  • Carmichael Hill & Associates opened 63 new positions and closed 145 in Q2 2022.
  • Carmichael Hill & Associates's portfolio value fell 12% quarter-over-quarter to $190M.

Based on Carmichael Hill & Associates's 13F filing for Q2 2022, filed 5 Aug 2022.